Package Leaflet: Information for the User
Menopur1200 IU solution for injection in pre-filled pen
Menotropin
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack
Menopur is presented as a solution for injection in a pre-filled pen. The injection is given under the skin (subcutaneous injection), usually in the abdomen.
Menopur contains menotropin which is a mixture of two natural hormones called:
These hormones help the reproductive organs to function normally. The FSH and LH hormones in menotropin are obtained from the urine of post-menopausal women.
What is Menopur used for
Menopur is used to treat women who cannot become pregnant. It is used for:
How Menopur works
Menopur helps the ovaries to develop many egg sacs (follicles) where an egg can develop. This is called "multiple follicular development".
Checks before using Menopur
Before starting treatment with Menotropin, you and your partner should be evaluated by a doctor to determine the cause of the infertility problem. In particular, you should be checked for the following diseases so that you can receive the most appropriate treatment:
If you know you have any of the diseases listed above, please inform your doctor before starting treatment with Menopur.
Do not use Menopur if:
Warnings and precautions
Ovarian Hyperstimulation Syndrome (OHSS)
A serious side effect of this medicine, especially in women with PCOS, is "ovarian hyperstimulation syndrome" or "OHSS" (see section 4).
Tell your doctor immediately if you have signs of OHSS, even if:
These can be signs of high levels of activity in the ovaries, which can become serious. If this happens, your doctor will stop your treatment with Menopur and treat you in a hospital.
Maintaining the recommended dose and careful monitoring of treatment will reduce the options for suffering from these symptoms.
Scans and tests
While you are being treated with this medicine, your doctor will normally send you for ultrasound scansand sometimes blood teststo monitor your response to treatment.
Pregnancy risks
When you are being treated with hormones like Menopur, the risk of:
Some women who have been treated with several medications for infertility have developed tumors in the ovaries and other reproductive organs. It is not yet known if treatment with hormones like this medicine causes these problems.
Blood clots
It is more likely that blood clots will form in the blood vessels (veins or arteries) in pregnant women. Infertility treatment may increase the likelihood of this happening, especially if you:
Tell your doctor if you think this applies to you.
Use in children
Menotropin is not indicated for use in children.
Other medicines and Menopur
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Clomifene citrate is another medicine used in the treatment of infertility. If menotropin is used at the same time as clomifene citrate, the effect on the ovaries may be increased.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, or think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Do not use Menopur if you are pregnant or breastfeeding.
Driving and using machines
It is very rare that Menopur affects the ability to drive and use machines.
Important information about some of the ingredients of Menopur
This medicine contains less than 1 mmol of sodium (23 mg) per dose unit; this is essentially "sodium-free".
Follow the instructions for administration of Menopur exactly as indicated by your doctor. If you are in doubt, consult your doctor or pharmacist again.
Women who do not ovulate (do not produce eggs):
Your treatment will start within the first 7 days of your menstrual cycle:
How much Menopur?
The initial dose is usually 75-150 IU per day.
Your doctor will monitor the effect of treatment with Menopur. The treatment cycle should be abandoned if you do not respond adequately after 4 weeks.
If you have a good response to Menopur
You will be given a single injection of a hormone called human chorionic gonadotropin (hCG).
It is recommended to have intercourse on the same day as the administration of hCG andthe next day. Alternatively, sperm can be injected directly into the uterus, known as artificial insemination.
If you do not respond to Menopur:
Women in assisted reproduction programs:
If you are in an assisted reproduction program, you will also have a medicine that helps a hormone called "gonadotropin-releasing hormone" (GnRH) to work. This other medicine is called a "GnRH agonist". Menopur should be started around 2 weeks after the start of therapy with GnRH agonists.
You may also be taking a medicine called a "GnRH antagonist".
Treatment with Menopur should be started on day 2 or 3 of the menstrual cycle (day 1 is the first day of your period).
How much Menopur?
Menopur should be administered every day for at least 5 days.
Normally, treatment should not continue for more than 20 days.
If there are enough egg sacs (or follicles), you will be given a single injection of hCG in a dose of up to 10,000 IU to trigger the release of an egg (ovulation).
Your doctor will closely monitor your progress for at least 2 weeks after you have been given the hCG injection.
Your doctor will monitor the effect of treatment with Menopur.
Otherwise, you should not have sexual intercourse until you have started your next period.
Using Menopur
Follow the "Instructions for use" carefully, which are supplied with the pre-filled pen.
A doctor or nurse will be present for your first injection of Menopur. Your doctor will decide if you can administer the following injections yourself at home, after you have received complete training.
Menopur will be administered as an injection under the skin (subcutaneous injection). This is usually in the abdomen. Each pre-filled pen can be used for several injections.
If you use more Menopur than you should.In case of overdose or if the solution is swallowed by accident, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount used.
If you forget to use Menopur,do not use a double dose to make up for forgotten doses. Please inform your doctor or pharmacist.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Ovarian Hyperstimulation Syndrome (OHSS)
Tell your doctor immediatelyif you experience any of the following, which can be signs of OHSS:
Tell your doctor immediately, even if it has been a few days since your last injection, or you stop using Menopur. You may need urgent medical treatment. These side effects can mean that your ovaries have been over-stimulated, which is known as ovarian hyperstimulation syndrome (OHSS). In severe cases of OHSS, fluid accumulation in the abdomen, pelvis or chest cavity, difficulty breathing, decreased urination, blood clots in the blood vessels (thromboembolism), and twisting of the ovaries (ovarian torsion) have been reported rarely.
Allergic reactions.
Tell your doctor immediately if you have:
If you experience any of these symptoms, contact your doctor immediately.
Other side effects
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Other side effects(frequency not known):
Reporting of side effects.
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System for Human Use https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the label of the pre-filled pen and on the carton after "EXP". The expiry date is the last day of the month indicated.
Before use:
Store in a refrigerator (2°C - 8°C).
Do not freeze.
After opening:
Use each pre-filled pen within 28 days of opening. Store below 25°C.
Always keep the pen with the cap on to protect it from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition ofMenopur
The active ingredient is highly purified menotropin (human menopausal gonadotropin, hMG)
A multidose pre-filled pen administers Menotropin corresponding to 1200 IU of follicle-stimulating hormone FSH activity and 1200 IU of luteinizing hormone LH activity.
Menotropin
The other components are:
Appearance of the Product and Container Contents.
Menopur is a clear and colorless injectable solution in a pre-filled pen.
Menopur 1200 IU injectable solution in a pre-filled pen is available in packs of 1 pre-filled pen and 21 injection needles.
Marketing Authorization Holder and Manufacturer:
Marketing Authorization Holder
Ferring, S.A.U
C/ del Arquitecto Sánchez Arcas nº 3, 1º
28040 Madrid
Spain
Manufacturer: FERRING GmbH
Wittland 11,
D-24109 Kiel
Germany
This Medicinal Product is Authorized in the Member States of theEconomic European Areawith the Following Names:
Belgium, Ireland, Luxembourg, Slovakia: Menotrophin Ferring
Czech Republic: Menotrophin Ferring-Léciva
Bulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, Greece, Hungary, Iceland, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden: Menopur
Germany: Menogon HP
Italy: Meropur
Date of the Last Revision of this LeafletJune 2022.
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
Instructions for Use
MENOPUR® Pre-filled Pen
Menopur injectable solution
Your healthcare professional (doctor, nurse, or pharmacist) should teach you how to prepare and inject Menopur properly before injecting it for the first time.
Read this manual completely before using the Menopur pre-filled pen and each time you acquire a new pen. There may be new information. Follow these instructions carefully, even if you have used a similar injectable pen before. Incorrect use of the pen may result in an incorrect dose of the medication.
Contact your healthcare professional if you have any questions about how to administer your Menopur injection.
The Menopur pre-filled pen is a disposable, dosing pen that can be used for the administration of more than 1 dose of Menopur. The numbers you see in the dose display window represent the number of International Units (IU) of Menopur. The pen is available in 2 different concentrations:
Instructions for Use –Menopur Pre-filled Pen
Information about your Menopur pre-filled pen
The pen can be set to administer doses of 6.25 IU to 450 IU of Menopur in marked increments of 6.25 IU.
Cleaning
Storage
Items You Will Need to Administer Your Menopur Injection
Before Use – (Step 1)
1.
Attaching the Needle – (Steps 2 to 6)
Important:
2.
3.
4.
5.
6.
7.
8.
9.
Dialing the Dose – (Step 10)
See “Examples of how to dial a dose” on pages 20 to 21.
Dose Division
See “Giving a divided dose of Menopur“ on pages 22 to 23 for examples of how to calculate and record your divided dose.
.
11.
12.
Note:
Disposing of the Needle – (Step 13)
13.
Note:
.
Replacing the Cap on the Pen – (Step 14)
14.
Note:
Disposal
Needles:Place used needles in a puncture-resistant container, such as a sharps container, immediately after use.
If you do not have a sharps container, you may use a household container that has the following characteristics:
You should dispose of the sharps container when it is almost full. Ask your doctor, nurse, or pharmacist what the right way to dispose of it is. Do not dispose of your used sharps container in household trash unless your community guidelines permit it.
Menopur Pre-filled Pens:
In the Following Pages, You Will Find More Information on the Topics Listed Below.1:• Examples of how to dial a dose...............................................................page 20 to 21 • Administration of a divided dose of Menopur.....................page 22 • Divided dose diary......................................................................... page 23 • Frequently Asked Questions (FAQ)............................................................page 24 • Warnings..................................................................................................page 25
Examples of How to Dial a Dose
Examples of how to dial a dose using your Menopur pre-filled pen
The graph on the right shows examples of prescribed doses, how to dial the examples of prescribed doses, and how the dose display window looks for the prescribed doses.
Examples of prescribed doses (in IU) (units) | Priming dose | 75 |
Dose to dial on pen | Priming symbol ((Dial a click starting from 0 until you see the priming drop symbol)) | 75 (Dial to 75) |
Dose display window for example prescribed dose |
118.75 | 225 | 262.5 | 343.75 | 450 |
118.75 (Dial to 112.5 plus 1 click) | 225 (Dial to 225) | 262.5 (Dial to 262.5) | 343.75 (Dial to 337.5 plus 1 click) | 450 (Dial to 450) |
Administration of a split dose ofMenopur
If you are unable to dial the complete dose that has been prescribed for you on your pen, this means that there is not enough medication left in the pen to administer the complete dose. You will need to administer part of your prescribed dose using the pen you were using, and the rest of the dose using a new pen (split dose injection) or you will need to discard the pen you were using and use a new pen to administer the complete dose that has been prescribed for you in a single injection. If you decide to administer the split dose in two injections, follow these instructions, and write down the amount of medication to be administered using the split dose diary on page 231.
Split Dose Diary
A Prescribed dose | B Dose remaining in the pen (Dose shown on the dose indicator in the dose display window) | C = A minus B Dose to inject in new pen (Dose shown on the dose indicator in the dose display window) |
112.5 | 75 (75) | 37.5 (37.5) |
125 | 50 (50) | 75 (75) |
300 | 181.25 (175 plus 1 line) | 118.75 (112.5 plus 1 line) |
Frequently Asked Questions (Q&A)
.
.
.
Precautions
Contact
If you have any questions or problems related to the pen, contact your healthcare professional or local representative of the marketing authorization holder.
Marketted by: Ferring SAU
C/ Arquitecto Sánchez Arcas nº3, 1º
28040 Madrid
Spain
Revised: June 2022